{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:03:42Z","timestamp":1791576222656,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.beem.2019.101346","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T02:12:13Z","timestamp":1571710333000},"page":"101346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Pheochromocytoma: An approach to diagnosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Emilia","family":"Sbardella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2019.101346_bib1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101346_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14568.1","article-title":"New insights on the pathogenesis of paraganglioma and pheochromocytoma","volume":"7","author":"Kantorovich","year":"2018","journal-title":"F1000Res"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: state-of-the-art and future prospects","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2019.101346_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0079-6123(10)82015-1","article-title":"Pheochromocytoma and paraganglioma","volume":"182","author":"Kantorovich","year":"2010","journal-title":"Prog Brain Res"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4158\/EP.6.3.249","article-title":"Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital","volume":"6","author":"Ariton","year":"2000","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib7","first-page":"637","article-title":"A\u00a0survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib9","first-page":"299","article-title":"Death from phaeochromocytoma: lessons from a post-mortem survey","volume":"29","author":"Platts","year":"1995","journal-title":"J\u00a0R Coll Phys Lond"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9610(00)00296-8","article-title":"Adrenal pheochromocytoma remains a frequently overlooked diagnosis","volume":"179","author":"Lo","year":"2000","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.beem.2019.101346_bib11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1445-5994.2000.tb04358.x","article-title":"Phaeochromocytoma discovered during coronial autopsies in sydney, melbourne and auckland","volume":"30","author":"McNeil","year":"2000","journal-title":"Aust N Z J Med"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of pediatric vs adult pheochromocytomas and paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1651-2227.1992.tb12213.x","article-title":"A\u00a0single pediatric center experience with 1025 children with hypertension","volume":"81","author":"Wyszynska","year":"1992","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12020-017-1310-9","article-title":"Routine genetic screening with a multi-gene panel in patients with pheochromocytomas","volume":"59","author":"Sbardella","year":"2018","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.beem.2019.101346_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jso.23157","article-title":"Hereditary pheochromocytoma and paraganglioma","volume":"106","author":"Mazzaglia","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"issue":"20","key":"10.1016\/j.beem.2019.101346_bib17","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.beem.2019.101346_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0031-1299707","article-title":"Metastatic pheochromocytoma and paraganglioma: focus on therapeutics","volume":"44","author":"Plouin","year":"2012","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.beem.2019.101346_bib19","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2019.101346_bib20","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM198507113130207","article-title":"Expression of neurofilament antigens by normal and neoplastic human adrenal chromaffin cells","volume":"313","author":"Trojanowski","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib22","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/EJE-13-0882","article-title":"Diagnosis of endocrine disease: biochemical diagnosis of phaeochromocytoma and paraganglioma","volume":"170","author":"van Berkel","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","author":"Eisenhofer","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"9","key":"10.1016\/j.beem.2019.101346_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1055\/s-0028-1128139","article-title":"The protean manifestations of pheochromocytoma","volume":"41","author":"Manger","year":"2009","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.beem.2011.10.008","article-title":"Subclinical phaeochromocytoma","volume":"26","author":"Mannelli","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2019.101346_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fendo.2019.00333","article-title":"Pheochromocytomas and paragangliomas as causes of endocrine hypertension","volume":"10","author":"Canu","year":"2019","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2019.101346_bib28","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2165\/00002018-200730110-00004","article-title":"Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management","volume":"30","author":"Eisenhofer","year":"2007","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14310\/horm.2002.1224","article-title":"Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension","volume":"8","author":"Frankton","year":"2009","journal-title":"Hormones (Basel)"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1022981801344","article-title":"Pheochromocytoma as an endocrine emergency","volume":"4","author":"Brouwers","year":"2003","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"10.1016\/j.beem.2019.101346_bib31","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J\u00a0Hypertens"},{"issue":"20","key":"10.1016\/j.beem.2019.101346_bib32","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2016.03.543","article-title":"Pheochromocytoma is characterized by catecholamine-mediated myocarditis, focal and diffuse myocardial fibrosis, and myocardial dysfunction","volume":"67","author":"Ferreira","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.beem.2019.101346_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.beem.2019.101346_bib34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/clinchem\/39.1.97","article-title":"Determination of metanephrines in plasma by liquid chromatography with electrochemical detection","volume":"39","author":"Lenders","year":"1993","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clinbiochem.2010.07.006","article-title":"Current status and future developments of LC-MS\/MS in clinical chemistry for quantification of biogenic amines","volume":"44","author":"de Jong","year":"2011","journal-title":"Clin Biochem"},{"issue":"19\u201320","key":"10.1016\/j.beem.2019.101346_bib37","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cca.2012.06.006","article-title":"Performance characteristics of an LC-MS\/MS method for the determination of plasma metanephrines","volume":"413","author":"Petteys","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.beem.2019.101346_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1530\/EJE-09-0996","article-title":"Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma","volume":"162","author":"Grouzmann","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2019.101346_bib39","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1011572617314","article-title":"Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma","volume":"2","author":"Eisenhofer","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.beem.2019.101346_bib41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00004872-200106000-00006","article-title":"Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma","volume":"19","author":"Gardet","year":"2001","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/clinchem\/40.2.250","article-title":"Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases","volume":"40","author":"Gerlo","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2019.101346_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1196\/annals.1353.038","article-title":"Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?","volume":"1073","author":"Grossman","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A\u00a0comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Pt 6","key":"10.1016\/j.beem.2019.101346_bib45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/000456320203900603","article-title":"Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines","volume":"39","author":"Davidson","year":"2002","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6823-4-2","article-title":"A\u00a0systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma","volume":"4","author":"Sawka","year":"2004","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-123-2-199507150-00004","article-title":"Plasma metanephrines in the diagnosis of pheochromocytoma","volume":"123","author":"Lenders","year":"1995","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.beem.2019.101346_bib48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2265.2007.02805.x","article-title":"The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma","volume":"66","author":"Perry","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib49","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/ERC-17-0269","article-title":"Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame","volume":"25","author":"Marotta","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040586","article-title":"Chromogranin a in the laboratory diagnosis of pheochromocytoma and paraganglioma","volume":"11","author":"Bilek","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1373\/clinchem.2006.076489","article-title":"Is supine rest necessary before blood sampling for plasma metanephrines?","volume":"53","author":"Lenders","year":"2007","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/00313020802579284","article-title":"Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma","volume":"41","author":"Hickman","year":"2009","journal-title":"Pathology"},{"issue":"11","key":"10.1016\/j.beem.2019.101346_bib53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00595-006-3291-9","article-title":"Adrenal incidentaloma: review of 197 patients and report of a drug-related false-positive urinary normetanephrine result","volume":"36","author":"Ito","year":"2006","journal-title":"Surg Today"},{"issue":"17","key":"10.1016\/j.beem.2019.101346_bib54","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.2010.1563","article-title":"Biochemical misdiagnosis of pheochromocytoma in patients treated with sulfasalazine","volume":"304","author":"Bouhanick","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib55","first-page":"5","article-title":"LC-MS\/MS in the clinical laboratory - where to from here?","volume":"32","author":"Grebe","year":"2011","journal-title":"Clin Biochem Rev"},{"issue":"6","key":"10.1016\/j.beem.2019.101346_bib56","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.beem.2019.101346_bib57","first-page":"251","article-title":"Cigarette smoking and the adrenergic nervous system","volume":"14","author":"Grassi","year":"1992","journal-title":"Clin Exp Hypertens"},{"issue":"23","key":"10.1016\/j.beem.2019.101346_bib58","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc1101502","article-title":"Drugs and pheochromocytoma-don't be fooled by every elevated metanephrine","volume":"364","author":"Neary","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"Pt 1","key":"10.1016\/j.beem.2019.101346_bib59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0004563213487894","article-title":"Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine","volume":"51","author":"Eisenhofer","year":"2014","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0004563218755817","article-title":"Falsely elevated plasma metanephrine in patients taking midodrine","volume":"55","author":"Emms","year":"2018","journal-title":"Ann Clin Biochem"},{"issue":"8","key":"10.1016\/j.beem.2019.101346_bib61","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Pt 1","key":"10.1016\/j.beem.2019.101346_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1258\/acb.2012.012066","article-title":"Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma","volume":"50","author":"Eisenhofer","year":"2013","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"10.1016\/j.beem.2019.101346_bib63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","author":"Yu","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6 Pt 1","key":"10.1016\/j.beem.2019.101346_bib64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.HYP.17.6.733","article-title":"Glucagon and clonidine testing in the diagnosis of pheochromocytoma","volume":"17","author":"Grossman","year":"1991","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib65","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiology.148.2.6867349","article-title":"Pheochromocytoma: value of computed tomography","volume":"148","author":"Welch","year":"1983","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the first international symposium. October 2005","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/110241598750004913","article-title":"Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and the French Association of Endocrine Surgeons (AFCE)","volume":"164","author":"Jalil","year":"1998","journal-title":"Eur J Surg"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2001.00792.x","article-title":"Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytoma","volume":"249","author":"Berglund","year":"2001","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","article-title":"Pheochromocytomas: detection with 18F DOPA whole body PET-initial results","volume":"222","author":"Hoegerle","year":"2002","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib70","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00259-009-1294-7","article-title":"Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography\/computed tomography (18F-DOPA PET\/CT) for detecting pheochromocytoma","volume":"37","author":"Luster","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiol.2223010766","article-title":"Adrenal masses: characterization with combined unenhanced and delayed enhanced CT","volume":"222","author":"Caoili","year":"2002","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.beem.2019.101346_bib72","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2214\/ajr.181.6.1811663","article-title":"Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma","volume":"181","author":"Blake","year":"2003","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-150-1-200901060-00006","article-title":"Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma","volume":"150","author":"Baid","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiology.165.1.3628794","article-title":"Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy","volume":"165","author":"Quint","year":"1987","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib75","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00330-004-2412-3","article-title":"CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas)","volume":"15","author":"Sahdev","year":"2005","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.beem.2019.101346_bib76","first-page":"1147","article-title":"Iodine-123-metaiodobenzylguanidine scintigraphy in patients with chemodectomas of the head and neck region","volume":"31","author":"van Gils","year":"1990","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.beem.2019.101346_bib77","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00330-008-1073-z","article-title":"Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function","volume":"18","author":"Jacques","year":"2008","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.beem.2019.101346_bib78","first-page":"217","article-title":"Nuclear medicine imaging of pheochromocytoma and neuroblastoma","volume":"43","author":"Sisson","year":"1999","journal-title":"Q\u00a0J Nucl Med"},{"issue":"6","key":"10.1016\/j.beem.2019.101346_bib79","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00173045","article-title":"Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours","volume":"21","author":"Hoefnagel","year":"1994","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF03401287","article-title":"The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas","volume":"12","author":"Rufini","year":"2013","journal-title":"Hormones (Basel)"},{"key":"10.1016\/j.beem.2019.101346_bib81","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00259-019-04435-z","article-title":"Current experts' views on precision nuclear medicine imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Taieb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.beem.2019.101346_bib82","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","article-title":"123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytoma: CT and MRI correlation","volume":"69","author":"Bhatia","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2019.101346_bib84","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","article-title":"Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial","volume":"50","author":"Wiseman","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.beem.2019.101346_bib85","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2009-1054","article-title":"6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess","volume":"94","author":"Fiebrich","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.beem.2019.101346_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10354-018-0658-7","article-title":"Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease","volume":"169","author":"Kroiss","year":"2019","journal-title":"Wien Med Wochenschr"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10689-004-2155-y","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"4","author":"Brink","year":"2005","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.beem.2019.101346_bib88","first-page":"32","article-title":"In\u00a0vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine","volume":"37","author":"Bergstrom","year":"1996","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib89","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.beem.2019.101346_bib90","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00259-012-2309-3","article-title":"68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET\/CT","volume":"40","author":"Kroiss","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.beem.2019.101346_bib91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/RLU.0000000000001674","article-title":"Comparison of the 68Ga-DOTATATA PET\/CT, FDG PET\/CT, and MIBG SPECT\/CT in the evaluation of suspected primary pheochromocytomas and paragangliomas","volume":"42","author":"Jing","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.beem.2019.101346_bib92","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","author":"Archier","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.beem.2019.101346_bib93","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.beem.2019.101346_bib94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","author":"Janssen","year":"2016","journal-title":"J\u00a0Nucl Med"},{"issue":"17","key":"10.1016\/j.beem.2019.101346_bib95","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Janssen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2019.101346_bib96","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fendo.2018.00515","article-title":"Update of pheochromocytoma syndromes: genetics, biochemical evaluation, and imaging","volume":"9","author":"Alrezk","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2019.101346_bib97","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fonc.2019.00053","article-title":"Clinical, diagnostic, and treatment characteristics of SDHA-related metastatic pheochromocytoma and paraganglioma","volume":"9","author":"Jha","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.beem.2019.101346_bib98","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1210\/jc.2017-00816","article-title":"Efficacy of peptide receptor radionuclide therapy for functional metastatic paraganglioma and pheochromocytoma","volume":"102","author":"Kong","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2019.101346_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070909","article-title":"Favorable outcome in patients with pheochromocytoma and paraganglioma treated with (177)Lu-DOTATATE","volume":"11","author":"Vyakaranam","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2019.101346_bib100","doi-asserted-by":"crossref","DOI":"10.1159\/000499497","article-title":"Peptide receptor radionuclide therapy as a novel treatment for metastatic and invasive phaeochromocytoma and paraganglioma","author":"Mak","year":"2019","journal-title":"Neuroendocrinology"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:32Z","timestamp":1761497792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X19300971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1521690X19300971"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2019.101346","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pheochromocytoma: An approach to diagnosis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2019.101346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101346"}}